London
A CLOSE association between the presence of atherosclerosis and the development of ischemic heart disease is widely accepted. However, ischemic heart disease may develop in the presence of remarkably little atherosclerosis of the coronary arteries, and gross coronary atherosclerosis may be present in individuals who never develop myocardial ischaemia. Other etiological factors in ischemic heart disease must be sought, and it has been supposed that increased coagulability of the blood may be one. Recently we have explored this possibility.
Investigation of Blood Coagulation in Ischwmic
Heart Disease
Blood coagulation was first compared in 48 patients with ischaemic heart disease and in 48 normal subjects of the same age and sex (McDonald, 1957; McDonald and Edgill, 1957) . All the patients had angina pectoris on exertion; although cardiac infarction had occurred previously in some of the cases, it was recent in none. The age and sex distribution were typical of ischmmic heart disease. The ages were from 40 to 62 years, average 53, and there were 42 men and 6 women.
Tests of blood coagulation, performed on patients and controls under uniform conditions, covered the various phases of blood coagulation: thromboplastin-generation test, platelet count 
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and estimation of platelet stickiness, fibrinogen estimation, two different prothrombin times (using Russell's-viper venom, Stypven, and brain extract, Thrombokinase, Geigy), three different contact-clotting times (using ground glass, Ballotini spheres, and a silicone tube), and estimation of factor VII in plasma and serum.
Comparison of the mean values for patients and normals showed significant differences in relation to thromboplastin generation ( Fig. 1 ), platelet stickiness ( Fig. 2) , fibrinogen estimation and prothrombin time (Russell's-viper venom, Stypven). These results indicated increased coagulability of the blood in the patients with ischmemic heart disease, compared to the normals of the same age and sex. The differences were significant at the 1 % level, except the prothrombin time (Russell's-viper venom, Stypven) where it was at the 5 % level. A statistically significant difference was not found between patients and controls in total platelet counts, contact-clotting times, estimation of factor VII in plasma and serum, or in the prothrombin times using brain extract (Thrombokinase, Geigy). Thus for the first time, hypercoagulability of the blood in ischemic heart disease was clearly demonstrated. Subsequently these differences were found to remain unaltered on repeated testing. In a joint examination-of platelet stickiness and thromboplastin generation, in 15 paired male patients and controls, a definite relation between the two tests was established for the patients but not the controls (Fig. 3 ).
Blood coagulation (i.e. thromboplastin generation, platelet stickiness, fibrinogen estimation, and prothrombin time using Stypven) was next compared in normal subjects and in patients with angina pectoris on exertion, acute coronary insufficiency, and recent cardiac infarction (McDonald and Edgill, 1959) . Mean values for platelet stickiness, fibrinogen estimation and thromboplastin generation significantly increased from normal subjects to patients with angina pectoris, and from these to patients with cardiac infarction (Fig. 4 ). The differences were significant at the 1 % level, except that between the mean values for patients with angina pectoris and cardiac infarction which was nearly significant at the 5 % level. Findings in acute coronary insufficiency were not significantly different from those in angina pectoris, except that the platelet count was significantly higher, at the 5% leve,lb in acute coronary insufficiency (see Table I ) than in normal subjects and patients with angina pectoris. This finding remains unexplained. -Blood coagulability with regard to platelet stickiness, fibrinogen estimation, and thromboplastin generation, in normals, and in patients with angina pectoris, acute coronary insufficiency and cardiac infarction. Reproduced from McDonald and Edgill (1959) The mean platelet count in patients with cardiac infarction was intermediate, and did not differ significantly from the others. On repeated testing platelet counts varied more in patients with ischemic heart disease than in normal subjects; this may be related to the increase found in acute coronary insufficiency. These studies therefore confirmed the hypercoagulability of the blood that we had described previously in patients with angina pectoris, and showed that hypercoagulability was greater after cardiac infarction. The facts are in full accord with the clinical observation that patients with ischemic heart disease have an increased tendency to thrombosis.
Discussion
The significance of hypercoagulability.-Tests of blood coagulation which are performed in vitro must be considered in relation to coagulability and thrombosis in vivo. They may be assumed to reflect coagulability of the blood in vivo, and thrombosis is likely to be associated with hypercoagulability. It would, of course, be preferable to study thrombosis within the patient, and impaired fibrinolysis and thrombolysis may yet prove to be of paramount importance. Absolute figures in any of the tests of blood coagulation may permit only limited interpretation; the comparison of normal subjects with patients, or of patients in different phases of their disease, is more valuable. Increased platelet stickiness may merely reflect the presence of intravascular thrombosis (Bobek and Cepelak, 1958) , and we have found it increased in extracardiac thrombotic conditions. An important question was whether hypercoagulability is a cause or an effect of ischemic heart disease. Relative hypercoagulability of the blood exists in some normal people, but there is no evidence as yet that this predisposes to ischimic heart disease. Hypercoagulability may well be an effect of ischmmic heart disease rather than a cause. This is not to deny that temporary hypercoagulability, followed by thrombosis, might not initiate the disease, nor that previous hypercoagulability might not increase with it. There are at least three possible reasons for hypercoagulability after recent cardiac infarction. A phase of hypercoagulability may immediately precede infarction, initiate coronary thrombosis, and persist after the acute episode. On the other hand, hypercoagulability may merely reflect the presence of recent thrombosis, or be caused by tissue damage and intravascular stasis. The natural history of ischamic heart disease could be affected by hypercoagulability of the blood in different ways. Thus an increased tendency to mural thrombosis, leading to atherosclerosis (Duguid, 1946) , and a greater likelihood of complete arterial occlusion by thrombosis, would be expected if hypercoagulability is associated with an increased tendency to thrombosis.
Anticoagulants.-Various anticoagulants act differently in restoring hypercoagulability of the blood towards normal. Thus heparin rapidly depresses thromboplastin generation to normal levels and below, and platelet stickiness is reduced towards normal, although the effect is less. Phenindione affects both these tests less. The possibility of heparin deficiency or overutilization is being further investigated. In anticoagulant therapy with phenindione, the optimum amount of the drug is usually judged by the prothrombin time. However, the amount of anticoagulant needed probably varies with the degree of hypercoagulability. It is not surprising that some patients develop thrombosis despite adequate treatment by phenindione as judged by the prothrombin time. Ideal anticoagulant therapy might be based onthe titration of the right anticoagulant against clotting factors which are known to be abnormal.
With -regard to anticoagulant therapy in the management of ischmmic heart disease, it seems reasonable to assume that any measure which safely corrects hypercoagulability and returns blood coagulation to normal should improve the prognosis.
Action offats.-It has been thought likely that the activity of platelets in blood coagulation is due to ethanolamine phosphatide or some related compound (O'Brien, 1956) ; but at present "not enough is known about the connexion between clotting and thrombosis to decide whether or not the part played by fats in blood coagulability is relevant to the mechanism of thrombosis" (Poole, 1958) . Modification of the diet may, however, produce an anticoagulant effect. Diminished platelet stickiness and lowered serum cholesterol have been found after the rice-fruit diet (McDonald and Edgill, 1958) , but there was no evidence that the change in stickiness was due to the reduction of cholesterol, as opposed to some other metabolic change. When serum-cholesterol was lowered by corn oil in hypercholesterolemic patients, coagulability of the blood remained unaltered (McDonald, Edgill and Murdoch, unpublished) .
Conclusion
There is clear evidence of phasic hypercoagulability when the blood of patients with ischiemic heart disease is studied in vitro. This is entirely in keeping with a variable hyperthrombotic state, and ischimic heart disease is marked clinically by episodes of thrombosis. IRRESPECTIVE of where the lesion lies the -surgeon can treat a patient with arterial insufficiency in only one or more of the following ways: arterial reconstruction designed to restore normal or nearly normal blood flow; an operation to increase the efficiency of the collateral circulation; an operation to reduce symptoms by limiting the function of ischemic tissues; and an amputation or excision of ischemic tissues.
Some patients with atherosclerosis develop arterial aneurysms and here the treatment is surgical whenever the location and clinical findings warrant it and the patient's general condition permits it.
Arterial Thrombosis and Stenosis Due to
Atherosclerosis Until recently surgeons have concentrated on -the management of patients after an artery has thrombosed (Rob, 1953 (Rob, , 1956 . Whilst our main efforts are likely to remain in this field I believe that gradually the emphasis will change. The results bf surgery in the prethrombotic stage of arterial stenosis are much better and I think that in five years surgeons will be concentrating on what is in some cases a curative operation and in some a prophylactic one-the removal of arterial *stenoses caused by atherosclerosis.
The reconstructive surgery of stenoses of the carotid and vertebral arteries (Eastcott et al., 1954; Rob and Wheeler, 1957) , of the renal arteries (Freeman et al., 1954; DeCamp and Birchall, 1958) and of the aortic arch syndrome (Warren and Triedman, 1957) is now an established procedure. The reconstructive surgery of stenosis of the superior mesenteric artery (Glotzer and Shaw, 1959) and of the coronary arteries (Cannon et al., 1959) is emerging from the experimental stage and, as our skill and knowledge increase, may also become established. In the abdominal aorta and the arteries of the -limbs many surgeons have already removed -arterial stenoses, as opposed to complete -thromboses, with excellent results (Rob, 1957) .
The procedures of choice for removing arterial -stenoses are thrombo-endarterectomy and direct suture. With these techniques arterial substitutes such as vein grafts, arterial transplants and plastic prostheses are rarely required-a great advantage because follow-up studies show much better results when an artery is reconstructed without the use of arterial substitutes. In my own series the thrombosis rate has been only 18 out of 167 thrombo-endarterectomies (10-8%) and 2 out of 37 direct sutures (5-4%); but when an arterial substitute has been used the incidence of thrombosis has risen to 90 out of 401 operations or 22-4%. These figures are for a follow-up of between one month and nine years, the average duration being more than two years.
The diagnosis of arterial stenosis as opposed to thrombosis.-The clinical effects of these two lesions may be identical, particularly in the case of the internal carotid artery. But more patients consult their doctor after a complete thrombosis has occurred because for obvious reasons the symptoms are usually more severe. It is of importance that a patient with a complete thrombosis of one artery may have a stenosis of one or more other arteries. It is from these patients that one can learn the diagnostic features of arterial stenosis as opposed to thrombosis.
Both lesions produce ischemic effects distal to the occlusion. The distal pulses are usually absent with a thrombosis and present, but reduced in volume, with a stenosis; but when the collateral circulation is particularly good they may be present with a complete occlusion. With exercise these pulses disappear in the latter two types. An oscillometer reveals similar findings. In our experience a particularly valuable physical sign is arterial auscultation: about half of the severe arterial stenoses which I have seen exhibited a systolic murmur on auscultation over the site of the stenosis. This murmur is different from the more diffuse murmur, also heard in part of diastole, which appears occasionally over a complete occlusion when the collateral circulation is particularly good. This systolic murmur over an arterial stenosis not only serves to diagnose the lesion but to locate it. For example, in many patients with stenosis of the renal arteries and hypertension it is possible to
